Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Biotechnological production of 11α hydroxylated steroids using recombinant bacteria.CSIC has developed a procedure for the biotechnological production of 11α hydroxylated steroids by generating and subsequent use of recombinant bacteria. These recombinant bacteria allow to perform microbial biotransformation processes that result in 11αhydroxylated steroid compounds from raw materials such as phytosterols and intermediate products efficiently and economically. These compounds have numerous applications in pharmacology. Companies are sought for implementing and commercializing the new technology under patent license agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Fabrication of tips for scanning probe microscopy with enhanced resolutionCSIC has developed tips for scanning probe microscopy (SPM) where an isolated nanoparticle is placed at the apex of the tip. The method allows to tailor the shape, size and composition of the nanoparticle improving the measuring capabilities of the tips. These novel tips are suitable for techniques that combine imaging, such as SPM and spectroscopy like tip-enhanced Raman spectroscopy (TERS). Industrial partners manufacturers of laboratory equipment are being sought to collaborate through a patent license agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Peptide for cancer control linked to IL13RCSIC has developed a peptide capable of inhibiting the signaling of IL-13 mediated by IL13Rα2. This peptide alone or within a nanoparticle or virus-like particles can be used in a pharmaceutical composition for the treatment of pathologies in which IL13Rα2 is overexpressed. This composition would be useful in the treatment and control of metastasis of colon cancer and other tumors (i.e glioblastoma), as well as in other pathologies such as asthma, atopic dermatitis or fibrosis. Industrial partners are being sought to develop and commercialized the products through a patent licence agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Piperidine derivatives for the control of Parkinson's and Alzheimer'sCSIC has synthesized a series of piperidine derivatives that are capable of inhibiting the activity of the enzyme phosphodiesterase-8 (PDE8). This inhibitory activity makes them useful for the treatment of neurodegenerative diseases in which this enzyme is overexpressed. The compounds developed are, therefore, a new therapeutic alternative for Alzheimer's disease, and Parkinson, among others. Industrial partners from pharmaceutical industry are being sought to develop and commercialized the compounds through a patent licence agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Regulatory compounds of synaptic transmission for the treatment of neurological diseasesThe CSIC and IRYCIS (Ramón y Cajal Institute for Health Research) have developed a group of compounds. These compounds have the ability to regulate the number of synapses that are formed between neurons, as well as the probability that neurotransmitters are released from these, because they have the capability of modulate the interactions that take place between the regulatory proteins NCS-1 and Ric8a that regulate these two independent processes. Due to these neuromodulatory properties, these compounds are useful for the treatment of neurological diseases as Alzheimer's disease, Huntington or Parkinson's diseases among others. Industrial partners from the ophthalmic or pharmaceutical industry are being sought to collaborate through a patent license agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Antibiotics to treat diseases caused by HelicobacterCSIC, the University of Zaragoza, Institute Pasteur, IISA and ARAID have developed chemical derivatives that act selectively against the bacterium Helicobacter pylori, managing to reduce the bacterial load and even eradicate gastric infections caused by it. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
AZAM KHAN posted this:
Co-Founder and COO at LexSet.ai
Center for Technology Transfer and Commercialization of Novosibirsk State UniversityCenter for Technology Transfer and Commercialization of Novosibirsk State UniversityTechnology Transfer Office
View ProfileCenter for Technology Transfer and Commercialization of Novosibirsk State University posted this:
Master’s Degree Program “Big Data Analytics and Artificial Intelligence”A university laboratory (Russia) has developed a master's degree program “Big Data Analytics and Artificial Intelligence”, which is distinguished for being project-oriented and arranged in such a way where students in the course acquire the necessary knowledge and skills through participation in the implementation of real-life projects of the laboratory. The laboratory is looking for partners to provide educational services to their staff. Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Molecular Method that radically improves the diagnosis of Hereditary hemorrhagic telangiectasia (HHT)Molecular Method that radically improves the diagnosis of Hereditary hemorrhagic telangiectasia (HHT). The Granada University, Health and Progress Foundation, and the CSIC have developed a diagnostic molecular system for the HHT by getting a simple liquid biopsy from the patient. Industrial partners are being sought to collaborate through a patent license agreement to use this molecular diagnostic system with the possibility of informatics support.
Nadiia KachaputUkrainian LaboratoriesNadiia Kachaput posted this:
Innovation Manager at Ukrainian Laboratories
Brunel University LondonBrunel University LondonBrunel University London posted this:
Casting Magnesium Alloy with Improved Thermal ConductivityA casting magnesium alloy that can provide significantly improved thermal conductivity in comparison to the commonly used AZ91D magnesium alloys. The typical thermal conductivity of the new magnesium alloy is comparable to the thermal conductivity of the commonly used A380 aluminium alloy.
Centre Technology Transfer CITTRUCentre Technology Transfer CITTRUCentre Technology Transfer CITTRU posted this:
New UV-blocker for sunscreen with high bactericidal activityThe offered material is based on ZnO nanoparticles, modified with biocompatible polymer – chitosan. The material is characterized by high absorption properties of the sun’s ultraviolet (UV) radiation. Also, high antibacterial activity against resistant bacterial strains and the absence of cytotoxic activity against human skin cells of the material were confirmed. Application: cosmetics, sunscreen, skincare, medical applications
Centre Technology Transfer CITTRUCentre Technology Transfer CITTRUCentre Technology Transfer CITTRU posted this:
A new method of the stereoselective synthesis of chosen medicinesThe subject of the offer is a new method of an asymmetric reduction of prochiral ketones and imines used in the synthesis of commonly used medicines, e.g. hormonal (eg. Cincalcet), pulmonary (eg. Salbutamol) and neurological ones (eg. Rasagiline).
